| News for nuclear medicine and molecular imaging professionals |  |
| |
|
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple
internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher.
The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may
be directed to SmartBrief at snmmi@smartbrief.com.
|
- Obama administration to unveil 10-year brain-mapping project
The Obama administration is looking to unveil next month a 10-year project to map the active human brain, called Brain Activity Map. Scientists say the project may pave the way for the development of technologies that will help improve understanding of neurological conditions such as Alzheimer's and Parkinson's disease. The project, which may be worth $3 billion over 10 years, may also allow for the creation of national brain "observatories," akin to astronomical observatories. The New York Times (tiered subscription model)
(2/17)
|
|
 | Your initiatives. Our technology. Together, we can reduce radiation exposure.
Utilizing a fully shielded, mobile design, the MEDRAD™ Intego™ enables sites to infuse doses-on-demand from a multi-dose vial, providing clinicians with added protection and more accurate, repeatable, patient-specific dosing. Click here to learn more. |
|
|
| Clinical News & Research
|  |  |
|
- Alzheimer's beyond amyloidosis: WMHs matter, too, study finds
 Amyloid accumulation may play a role in the development of Alzheimer’s disease, but it may not be enough to diagnose the disease, according to a study published in JAMA Neurology. Small-vessel cerebrovascular disease, which manifests as white matter hyperintensities, may also play a role in the development of the disease, the study said, and the combined factors appear to be involved in manifestation of disease. The researchers used C-11-PIB-PET imaging to detect amyloid buildup and structural MRI to measure WMH. "The findings suggest a role of small-vessel cerebrovascular disease in the clinical presentation of AD and point to the importance of incorporating WMH into the formulation of pathogenic models of the disease," the researchers wrote. MolecularImaging.net
(2/17)
| Industry Report
| | |
|
| News from the Field
| | |
|
- Spectroscopy method detects fake malaria-fighting tablets
Researchers from the U.K. said a method related to NMR spectroscopy, known as nuclear quadrupole resonance spectroscopy, can be an effective way to detect fake drugs. Researchers used the technique to detect fake Metakelfin, an antimalarial drug, finding that the counterfeit tablets contained only 43% of the necessary amount of sulfalene. Researchers hope the method can be modified to identify other counterfeit drugs and harnessed for the development of a portable fake-drug detector. The findings were published in Analytical Chemistry. Chemical & Engineering News
(2/18)
| Health Policy
| | |
|
- CMS proposes MLR requirements for Medicare Advantage, Part D
A CMS rule proposed Friday lays out medical loss ratio requirements for Medicare plans under the Affordable Care Act. Medicare Part D and Medicare Advantage plans must spend 85% of revenue on quality improvements, prescription drugs, clinical services and other clear patient benefits, the CMS said. Plans that fail to meet the requirements would see enrollment sanctions after three years in a row, and contracts would be terminated after failing to meet requirements for five consecutive years. MedPage Today (free registration)
(2/18)
, PharmaTimes (U.K.)
(2/18)
- Drug price controls would harm innovation
 Letting the government negotiate prices for Medicare Part D would be a step toward government control of drug prices and would keep future cures off the shelves, writes Dr. Adam Dorin, president and founder of America's Medical Society. America's health costs are a result of the nation's role in leading the way in introducing life-saving innovations, he writes. The Washington Times/Communities blog
(2/17)
| Advancing Health Care
| | |
|
| From SNMMI
| | |
|
| SmartQuote
| | |
|
 | Everything that lives, lives not alone, nor for itself."
--William Blake,
British poet and painter
|
| |
| |
|
Read more at
SmartBrief.com |
|
|
|
| |
| |
| | Recent
SNMMI SmartBrief Issues:
- Monday, February 18, 2013
- Friday, February 15, 2013
- Thursday, February 14, 2013
- Wednesday, February 13, 2013
- Tuesday, February 12, 2013
| | | Lead Editor:
Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | |
| |
|
| © 1999-2013 SmartBrief, Inc.®
Legal Information |
|
